TBnet webinar October 2022


We welcome you to the TBnet monthly webinar on Thursday, 27 October 2022 at 16:00 CEST!

In this webinar, the Journal club - the ZeNix study (Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis) will be presented and discussed.


Join us on Zoom!

Link: https://us06web.zoom.us/j/85466248753?pwd=cTl2ZkVVSUVEYy9LQlZqQ1ovdmdCZz09

Meeting ID: 854 6624 8753

Passcode: 344519

 

Our speakers:


Prof Carole Mitnick- Harward Medical School, Partners in Health (PIH)

Carole Mitnick, Sc.D. is co-PI of the endTB and endTB-Q trials and PIH Director of Research for the endTB project. She is Professor of Global Health & Social Medicine at Harvard Medical School (HMS) and Associate Epidemiologist in the Division of Global Health Equity at Brigham & Women’s Hospital (BWH). She joined PIH in 1996 and she has worked closely with PIH sites in Peru, Kazakhstan, and Lesotho to strengthen research capacity as well as the links between direct, comprehensive care and research. She has contributed to numerous international (WHO, CDC/ATS) guidelines on the treatment of MDR-TB. Committed to improving the long-term quality of life for people who experience TB, in 2021, Dr. Mitnick also launched research in interventions for post-TB lung disease.


Dr. Catherine Berry- MSF UK

Catherine is an infectious diseases physician (FRACP) with over 12 years of clinical experience in internal medicine. Whilst completing a Masters in Public Health and Tropical Medicine, she joined MSF in 2014 working in Uzbekistan and Jordan. She is a conjoint lecturer with the University of Newcastle. She has extensive experience in research coordination as well as the care of MDR-TB patients. She has been involved in TB-PRACTECAL Clinical Trial since its start, currently she coverss the role of Global PI for the study.


Chair of the webinar:


Dr Ilaria Motta - MSF UK

She is an infectious diseases physician with experience in managing HIV and TB infections in resource limited settings with MSF in 2014 (Central Africa Republic) and other Italian NGO in 2011 (Burundi). In 2018, she obtained her PhD in pharmacokinetics of TB drugs. Since 2017 she has been in the role of medical monitor for TB-PRACTECAL, MSF-UK. Ilaria also collaborates as a clinical adviser to the EndTB clinical trial with MSF-France and she is a candidate for MSc Public Health at LSHTM.




355 views0 comments

Recent Posts

See All